Methylene Blue in the Therapy of Vasoplegic Syndrome after Cardiac Surgery Procedure
Authors:
H. Říha; L. Říhová; M. Pinďák; A. Březina; J. Pirk 1
Authors‘ workplace:
Klinika anesteziologie a resuscitace – Kardiocentrum IKEM, Praha
; Klinika kardiovaskulární chirurgie – Kardiocentrum IKEM, Praha
1
Published in:
Čas. Lék. čes. 2006; 145: 322-324
Category:
Case Report
Overview
Vasoplegic syndrome after cardiac surgery with cardiopulmonary bypass is severe complication with high morbidity and mortality. Without appropriate therapy the syndrome advances to the shock state with subsequent multiorgan failure. Basic haemodynamic parameters of vasoplegic syndrome include low systemic vascular resistance with severe hypotension, tachycardia, and normal or increased cardiac output and low filling pressures. In therapy norepinephrine and vasopressin or its analogues are used. Methylene blue is other therapeutic option. The case of successful application of methylene blue for the treatment of vasoplegic syndrome is presented.
Key words:
vasoplegic syndrome, methylene blue, cardiopulmonary bypass.
Labels
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain management Dental HygienistArticle was published in
Journal of Czech Physicians
![Issue 4](https://www.prolekare.cz/media/cache/resolve/journal_issue/media/image_pdf/a158120253b137547ea063ae856f9470.jpeg)
Most read in this issue
- Purkynje Fibers of the Heart Conduction System – History and the Present Time
- Larva migrans cutanea
- Long-lasting Cardiostimulation in the Treatment of Heart Failure
- Pulmonary Endarterectomy – The Surgical Treatment of Chronic Thromboembolic Pulmonary Hypertension